NRBO NeuroBo Pharmaceuticals Forecast, Technical & Fundamental Analysis

a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders.

Industry Biotechnology

Get AI intraday signals

NRBO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For NRBO
(Try 14 days for Free)

View a ticker or compare two or three

Compare

NRBO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For NRBO
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

NRBO is expected to report earnings to rise 33.33% to -11 cents per share on March 29

NeuroBo Pharmaceuticals NRBO Stock Earnings Reports

Q4'23

Est.

$-0.12

Q3'23

Beat

by $0.02

Q2'23

Beat

by $0.11

Q1'23

Beat

by $0.53

Q4'22

Beat

by $6.13

The last earnings report on November 13 showed earnings per share of -9 cents, beating the estimate of -10 cents. With 55.30K shares outstanding, the current market capitalization sits at 20.59M.

A.I. Advisor

published General Information

General Information

a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

545 Concord Avenue

Phone

+1 857 702-9600

Employees

Web

https://www.neurobopharma.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	27.37	0.91	+3.44%
GameStop Corp
AAPL	228.22	3.10	+1.38%
Apple
SPY	593.35	-3.84	-0.64%
SPDR® S&P 500® ETF Trust
BTC.X	87250.430000	-3333.734400	-3.68%
Bitcoin cryptocurrency
TSLA	311.18	-19.06	-5.77%
Tesla

NRBO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NRBO has been loosely correlated with ETXPF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NRBO jumps, then ETXPF could also see price increases.

Ticker / NAME	Correlation To NRBO	1D Price Change %
NRBO	100%	N/A
ETXPF - NRBO	51% Loosely correlated	N/A
ARGX - NRBO	43% Loosely correlated	+0.91%
BLUE - NRBO	37% Loosely correlated	-3.66%
HOOK - NRBO	32% Poorly correlated	-4.74%
MGTX - NRBO	30% Poorly correlated	+5.71%
More